Pharma IPR Conference
February 15, 2024, 6:43 PM
Axinn is proud to be a Platinum Partner of the Pharma IPR Conference
- On March 5 at 11:00 AM, partners Aziz Burgy, Ted Mathias, and counsel Rebecca Clegg are excited to conduct a panel discussion covering “Polymorph Patents: Infringement and Invalidity Challenges.”
We Know Pharma … and They Know Us
Axinn is the go-to firm for IP matters of strategic importance and offers one of the leading pharmaceutical practices in the country. Our team combines its depth of substantive patent law and litigation experience with FDA and antitrust knowledge to offer clients a unique and holistic offering. Whether leading a patent trial on a blockbuster product or navigating the complex FDA regulatory regime, Axinn enables pharmaceutical clients to bring their products to market in the most profitable manner possible.
We've worked on some of the most successful products in the pharmaceutical industry representing over $30 billion in annual sales, including:

Extensive Pharmaceutical Industry Experience

Contact Us
Please reach out to any of our attorneys attending the conference. You can set up a time to meet with an individual attorney using the email link in their contact details.
Aziz Burgy Partner aburgy@axinn.com | Rebecca Clegg Counsel rclegg@axinn.com | ||
Ted Mathias Partner tmathias@axinn.com |

To subscribe to our publications, click here.
Tags
News & Insights
News & Insights
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
29th Annual IBA Competition Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
MCCA Pathways Conference
Sponsorship
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
Entresto Trade Dress Dispute: No Injunctive Relief for Novartis
Axinn Viewpoints
Intellectual Property
ACI 12th Annual Summit for Women Leaders in Life Sciences Law
Speaking Engagement
Intellectual Property